TACE Combined With Lenvatinib for Unresectable Hepatocellular Carcinoma (Prolong)

Clinical trial NCT04560751 · UNKNOWN

Trial details

NCT number: NCT04560751
Sponsor: Zhejiang Cancer Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

Carcinoma, Hepatocellular

Start date: 2020-09-30
Primary completion: 2021-12-31
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.